|
|
|
Volumn 26, Issue 2, 2012, Pages
|
|
Vismodegib granted FDA approval for treatment of basal cell carcinoma.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANILIDE;
ANTINEOPLASTIC AGENT;
PYRIDINE DERIVATIVE;
VISMODEGIB;
ARTICLE;
BASAL CELL CARCINOMA;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
SKIN TUMOR;
UNITED STATES;
ANILIDES;
ANTINEOPLASTIC AGENTS;
CARCINOMA, BASAL CELL;
DRUG APPROVAL;
HUMANS;
PYRIDINES;
SKIN NEOPLASMS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84861161918
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|